Monthly Archives: February 2019

25 February 2019

Petmedix – Parkwalk’s latest investment

By |February 25th, 2019|

Parkwalk are delighted to announces its investment in Petmedix. The Cambridge based pet therapeutics company raises £8M Series A funding, with Parkwalk co-investing alongside Digitalis Ventures. Parkwalk were attracted by the team and the market potential.

PetMedix is applying 30 years of antibody research and the scientific work of two of its founders, Professor Allan Bradley […]

Parkwalk wins ‘Best EIS Fund Manager’ at the EIS Association Awards

By |February 8th, 2019|

Parkwalk are delighted to have won ‘Best EIS Fund Manager’ for 2018 at the annual EIS Association Awards. This is the 3rd year in a row that we have won this prodigious award.

The judges commented that Parkwalk were ‘An impressive manager with a strong track record and regular exits. Exactly what the regulator is looking for […]